|
Unique ID
|
Age (years)
|
PSA (ng/mL)
|
Prior therapies*
|
Events on FACS
|
Confirmed CTCs by IF
|
|---|
|
11001
|
61
|
1077
|
L, B, K, O, D, M
|
1700
|
22
|
|
11002
|
80
|
787
|
L, D+/-Da
|
294
|
17
|
|
11003
|
88
|
124.3
|
L, B
|
94
|
0
|
|
11004
|
76
|
201.3
|
L, T, B, N, D
|
0
|
0
|
|
11005
|
80
|
741
|
L, F, D, M, E vs pl
|
4
|
1
|
|
11006
|
58
|
168.1
|
L, B, D
|
0
|
0
|
|
11007
|
62
|
34.24
|
L, B, D, E
|
3
|
0
|
|
11008
|
63
|
1971
|
L, B, D, M + I
|
751
|
17
|
|
11009
|
62
|
68.45
|
L, B, D, M
|
60
|
4
|
|
11010
|
79
|
2229
|
L, B, D, M, Ctx
|
62
|
0
|
|
11011
|
71
|
218.9
|
L, B, D+/- Af, E
|
345
|
23
|
|
11012
|
70
|
1425
|
L
|
290
|
25
|
|
11013
|
72
|
50.15
|
L, B, F, K, O
|
431
|
22
|
|
11014
|
81
|
25.5
|
L, B, O, T
|
237
|
10
|
|
11015
|
80
|
70.8
|
L, B, Di, D, S
|
86
|
3
|
- *Prior therapies: A = aflibercept, B = bicalutamide, C = cyclophosphamide, Ci = cixutumumab, D = docetaxel, Da = dasatinib, Di = diethylstilbestrol, E = enzalutamide, F = flutamide, K = ketoconazole, L = LHRH agonist, M = mitoxantrone, N = nilutamide, O = orteronel, P = placebo, S = samarium lexidronam, T = tasquinimod.
